SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-25-001076
Filing Date
2025-01-06
Accepted
2025-01-06 08:00:30
Documents
14
Period of Report
2025-01-06
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm251576d1_8k.htm   iXBRL 8-K 27939
2 EXHIBIT 99.1 tm251576d1_ex99-1.htm EX-99.1 5409
  Complete submission text file 0001104659-25-001076.txt   209101

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA pbh-20250106.xsd EX-101.SCH 3039
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE pbh-20250106_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pbh-20250106_pre.xml EX-101.PRE 22376
16 EXTRACTED XBRL INSTANCE DOCUMENT tm251576d1_8k_htm.xml XML 3571
Mailing Address 660 WHITE PLAINS RD. TARRYTOWN NY 10591
Business Address 660 WHITE PLAINS RD. TARRYTOWN NY 10591 (914) 524-6800
Prestige Consumer Healthcare Inc. (Filer) CIK: 0001295947 (see all company filings)

IRS No.: 201297589 | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-32433 | Film No.: 25509083
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)